戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 maging reproducibility and interobserver and intraobserver variability.
2 t set conditions to establish a baseline for intraobserver variability.
3 stry suffer from a high degree of inter- and intraobserver variability.
4 omly selected patients was used to determine intraobserver variability.
5  months after the first session to determine intraobserver variability.
6  analysis of cellular morphology with inter-/intraobserver variability.
7         Variability of PWV was low: 0.7% for intraobserver variability, 1.5% for interobserver variab
8 e ascending aorta (AA) with COVs of 3.6% for intraobserver variability, 10.7% for interobserver varia
9 he interobserver variability (37% to 7%) and intraobserver variability (19% to 8%).
10 ing aorta (DDA) with median COVs of 1.6% for intraobserver variability, 4.0% for interobserver variab
11             In addition to interobserver and intraobserver variability and technical confounders, thi
12 tablish interobserver variability, to assess intraobserver variability, and to evaluate means of impr
13 ion methods were tested in 100 patients, and intraobserver variabilities as well as comparison with c
14  assessment, the 6-SD threshold yielded less intraobserver variability (difference, 0.6 g +/- 8, kapp
15                       Substantial inter- and intraobserver variability exists in the cytopathologic a
16                       We analyzed inter- and intraobserver variability for specific pathologies and a
17 al of this study was to determine inter- and intraobserver variability in measurement of pulmonary ar
18              To assess the interobserver and intraobserver variability in the clinical evaluation of
19                                              Intraobserver variability in this procedure as well as d
20               Outcome variables consisted of intraobserver variability (in a subsample of 40 cases) a
21 ver variability of -0.1 g +/- 2.3 and a mean intraobserver variability of 0.2 g +/- 1.6 at every-sect
22 Altman analysis was performed for inter- and intraobserver variability of cannulation time.
23          We determined the interobserver and intraobserver variability of HRCT findings and correlate
24                               The inter- and intraobserver variability of MBF quantitation with dynam
25                                   Inter- and intraobserver variability of radiologists' interpretatio
26                                          The intraobserver variability of sonographic measurements wa
27 h recent carotid events, assessed inter- and intraobserver variability of such measurements, and expl
28                       To overcome inter- and intraobserver variability of visual assessment, the auth
29               The first and second reads for intraobserver variability resulted in mean computational
30                                    Regarding intraobserver variability, the first radiologist had nea
31   For the determination of HF-US volume, the intraobserver variability was 9.7% +/- 5.1% (n = 8), and
32                                              Intraobserver variability was higher for visual EF than
33                            Interobserver and intraobserver variability was smallest for linear polyp
34                                   Inter- and intraobserver variabilities were assessed by using weigh
35                                   Inter- and intraobserver variabilities were determined by means of
36 o PET quantification methods with inter- and intraobserver variability were assessed.
37                       Substantial inter- and intraobserver variability were observed for all tonomete
38 is affected by substantial interobserver and intraobserver variability, which often leads to inapprop